These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30242495)

  • 1. Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis.
    Mader MM; Czorlich P; König C; Fuhrmann V; Kluge S; Westphal M; Grensemann J
    Acta Neurochir (Wien); 2018 Nov; 160(11):2099-2105. PubMed ID: 30242495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study.
    König C; Martens-Lobenhoffer J; Czorlich P; Westphal M; Bode-Böger SM; Kluge S; Grensemann J
    Ann Clin Microbiol Antimicrob; 2023 Apr; 22(1):29. PubMed ID: 37095559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion.
    Tiede C; Chiriac U; Dubinski D; Raimann FJ; Frey OR; Röhr AC; Wieduwilt A; Eibach M; Filmann N; Senft C; Zacharowski K; Seifert V; Mersmann J
    Antibiotics (Basel); 2021 Nov; 10(11):. PubMed ID: 34827359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study.
    Blassmann U; Roehr AC; Frey OR; Vetter-Kerkhoff C; Thon N; Hope W; Briegel J; Huge V
    Crit Care; 2016 Oct; 20(1):343. PubMed ID: 27776537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations.
    Lonsdale DO; Udy AA; Roberts JA; Lipman J
    J Neurosurg; 2013 Feb; 118(2):297-301. PubMed ID: 23121433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dosing nomograph for cerebrospinal fluid penetration of meropenem applied by continuous infusion in patients with nosocomial ventriculitis.
    König C; Grensemann J; Czorlich P; Schlemm E; Kluge S; Wicha SG
    Clin Microbiol Infect; 2022 Jul; 28(7):1022.e9-1022.e16. PubMed ID: 35182756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study.
    Blassmann U; Hope W; Roehr AC; Frey OR; Vetter-Kerkhoff C; Thon N; Briegel J; Huge V
    J Antimicrob Chemother; 2019 Apr; 74(4):991-996. PubMed ID: 30689877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meropenem pharmacokinetics in cerebrospinal fluid: comparing intermittent and continuous infusion strategies in critically ill patients-a prospective cohort study.
    Wicha SG; Kinast C; Münchow M; Wittova S; Greppmair S; Kunzelmann AK; Zoller M; Paal M; Vogeser M; Habler K; Weig T; Terpolilli N; Heck S; Dimitriadis K; Scharf C; Liebchen U
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0045124. PubMed ID: 39082803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of continuous-infusion meropenem for the treatment of Serratia marcescens ventriculitis in a pediatric patient.
    Cies JJ; Moore WS; Calaman S; Brown M; Narayan P; Parker J; Chopra A
    Pharmacotherapy; 2015 Apr; 35(4):e32-6. PubMed ID: 25884534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring intraventricular vancomycin for ventriculostomy access device infection in preterm infants.
    Parasuraman JM; Albur M; Fellows G; Heep A
    Childs Nerv Syst; 2018 Mar; 34(3):473-479. PubMed ID: 29067501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid Penetration of Vancomycin During Continuous Infusion Therapy in Patients With Nosocomial Ventriculitis.
    Tuon FF; Yamada CH; Cieslinski J; Dos Santos Oliveira D; Ribeiro VST; Gasparetto J; Telles JP
    Ther Drug Monit; 2021 Dec; 43(6):807-811. PubMed ID: 34780393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic monitoring of cerebrospinal fluid vancomycin concentrations and analysis of their influencing factors in neurosurgical intensive care unit patients].
    Yao M; Li J; Shi L; Li Y; Wang L; Guan X; Ouyang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct; 31(10):1252-1257. PubMed ID: 31771724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of vancomycin trough level in serum and cerebrospinal fluid of patients with acute community-acquired meningitis: a prospective study.
    Shokouhi S; Alavi Darazam I
    J Infect; 2014 Nov; 69(5):424-9. PubMed ID: 24973553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid/serum albumin ratio.
    Ishikawa M; Yamazaki S; Suzuki T; Uchida M; Iwadate Y; Ishii I
    J Infect Chemother; 2019 Feb; 25(2):124-128. PubMed ID: 30424949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study.
    Ricard JD; Wolff M; Lacherade JC; Mourvillier B; Hidri N; Barnaud G; Chevrel G; Bouadma L; Dreyfuss D
    Clin Infect Dis; 2007 Jan; 44(2):250-5. PubMed ID: 17173226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Meropenem in Neurocritical Care Patients: a Prospective Two-Center Study.
    Kumta N; Heffernan AJ; Cotta MO; Wallis SC; Livermore A; Starr T; Wong WT; Joynt GM; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0014222. PubMed ID: 35862757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review.
    Beach JE; Perrott J; Turgeon RD; Ensom MHH
    Clin Pharmacokinet; 2017 Dec; 56(12):1479-1490. PubMed ID: 28528396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies.
    Germovsek E; Lutsar I; Kipper K; Karlsson MO; Planche T; Chazallon C; Meyer L; Trafojer UMT; Metsvaht T; Fournier I; Sharland M; Heath P; Standing JF;
    J Antimicrob Chemother; 2018 Jul; 73(7):1908-1916. PubMed ID: 29684147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis].
    Jourdan C; Convert J; Peloux A; Boussaid O; Grando J; Tigaud S
    Pathol Biol (Paris); 1996 May; 44(5):389-92. PubMed ID: 8758482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients.
    Schoenenberger-Arnaiz JA; Ahmad-Diaz F; Miralbes-Torner M; Aragones-Eroles A; Cano-Marron M; Palomar-Martinez M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e30-e35. PubMed ID: 32296502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.